177 related articles for article (PubMed ID: 25293413)
1. Regulation of the alternative pathway of complement modulates injury and immunity in a chronic model of dextran sulphate sodium-induced colitis.
Elvington M; Schepp-Berglind J; Tomlinson S
Clin Exp Immunol; 2015 Mar; 179(3):500-8. PubMed ID: 25293413
[TBL] [Abstract][Full Text] [Related]
2. Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis.
Schepp-Berglind J; Atkinson C; Elvington M; Qiao F; Mannon P; Tomlinson S
J Immunol; 2012 Jun; 188(12):6309-18. PubMed ID: 22566568
[TBL] [Abstract][Full Text] [Related]
3. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.
Rohrer B; Long Q; Coughlin B; Wilson RB; Huang Y; Qiao F; Tang PH; Kunchithapautham K; Gilkeson GS; Tomlinson S
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3056-64. PubMed ID: 19264882
[TBL] [Abstract][Full Text] [Related]
4. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
Lu F; Fernandes SM; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
[TBL] [Abstract][Full Text] [Related]
5. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.
Sekine H; Kinser TT; Qiao F; Martinez E; Paulling E; Ruiz P; Gilkeson GS; Tomlinson S
Arthritis Rheum; 2011 Apr; 63(4):1076-85. PubMed ID: 21452327
[TBL] [Abstract][Full Text] [Related]
6. A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis.
Elvington M; Blichmann P; Qiao F; Scheiber M; Wadsworth C; Luzinov I; Lucero J; Vertegel A; Tomlinson S
Clin Exp Immunol; 2014 Aug; 177(2):500-8. PubMed ID: 24730624
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.
Schmidt CQ; Harder MJ; Nichols EM; Hebecker M; Anliker M; Höchsmann B; Simmet T; Csincsi ÁI; Uzonyi B; Pappworth IY; Ricklin D; Lambris JD; Schrezenmeier H; Józsi M; Marchbank KJ
Immunobiology; 2016 Apr; 221(4):503-11. PubMed ID: 26792457
[TBL] [Abstract][Full Text] [Related]
8. Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement.
Alawieh A; Elvington A; Zhu H; Yu J; Kindy MS; Atkinson C; Tomlinson S
J Neuroinflammation; 2015 Dec; 12():247. PubMed ID: 26714866
[TBL] [Abstract][Full Text] [Related]
9. Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.
Banda NK; Levitt B; Glogowska MJ; Thurman JM; Takahashi K; Stahl GL; Tomlinson S; Arend WP; Holers VM
J Immunol; 2009 Nov; 183(9):5928-37. PubMed ID: 19828624
[TBL] [Abstract][Full Text] [Related]
10. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
Huang Y; Qiao F; Atkinson C; Holers VM; Tomlinson S
J Immunol; 2008 Dec; 181(11):8068-76. PubMed ID: 19017999
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway.
Banda NK; Takahashi K; Wood AK; Holers VM; Arend WP
J Immunol; 2007 Sep; 179(6):4101-9. PubMed ID: 17785849
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional role of dextran sulfate sodium for in vivo modeling of intestinal diseases.
Rose WA; Sakamoto K; Leifer CA
BMC Immunol; 2012 Aug; 13():41. PubMed ID: 22853702
[TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
[TBL] [Abstract][Full Text] [Related]
14. Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration.
Annamalai B; Parsons N; Nicholson C; Joseph K; Coughlin B; Yang X; Jones BW; Tomlinson S; Rohrer B
Exp Eye Res; 2021 Jun; 207():108583. PubMed ID: 33878326
[TBL] [Abstract][Full Text] [Related]
15. The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.
Elvington A; Atkinson C; Zhu H; Yu J; Takahashi K; Stahl GL; Kindy MS; Tomlinson S
J Immunol; 2012 Nov; 189(9):4640-7. PubMed ID: 23028050
[TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE.
Hu X; Tomlinson S; Barnum SR
Neurosci Lett; 2012 Nov; 531(1):35-9. PubMed ID: 23079547
[TBL] [Abstract][Full Text] [Related]
17. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells.
Kiyohara H; Sujino T; Teratani T; Miyamoto K; Arai MM; Nomura E; Harada Y; Aoki R; Koda Y; Mikami Y; Mizuno S; Naganuma M; Hisamatsu T; Kanai T
Cell Mol Gastroenterol Hepatol; 2019; 7(1):135-156. PubMed ID: 30510995
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-19 protects mice from innate-mediated colonic inflammation.
Azuma YT; Matsuo Y; Kuwamura M; Yancopoulos GD; Valenzuela DM; Murphy AJ; Nakajima H; Karow M; Takeuchi T
Inflamm Bowel Dis; 2010 Jun; 16(6):1017-28. PubMed ID: 19834971
[TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of serotonin type 7 (5-HT7) receptor function modulates immune responses and reduces the severity of intestinal inflammation.
Kim JJ; Bridle BW; Ghia JE; Wang H; Syed SN; Manocha MM; Rengasamy P; Shajib MS; Wan Y; Hedlund PB; Khan WI
J Immunol; 2013 May; 190(9):4795-804. PubMed ID: 23554310
[TBL] [Abstract][Full Text] [Related]
20. Role of mannose-binding lectin in intestinal homeostasis and fungal elimination.
Choteau L; Parny M; François N; Bertin B; Fumery M; Dubuquoy L; Takahashi K; Colombel JF; Jouault T; Poulain D; Sendid B; Jawhara S
Mucosal Immunol; 2016 May; 9(3):767-76. PubMed ID: 26442658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
